Phenolic compounds naturally present in olive oil and lowering of blood LDL‐cholesterol and systolic blood pressure, therefore reducing the risk of coronary heart disease: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006

Documenti analoghi

• Creatine and improvement in cognitive function: Evaluation of a health claim pursuant to article 13(5) of regulation (EC) No 1924/2006
  di: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
  Pubblicazione: (2024-11-01)
• Anxiofit‐1 and reduction of subthreshold and mild anxiety: Evaluation of a health claim pursuant to article 14 of regulation (EC) No 1924/2006
  di: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
  Pubblicazione: (2026-03-01)
• Olive oil polyphenols and the maintenance of normal HDL‐cholesterol concentrations: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
  di: EFSA Panel on Nutrition, Novel Foods and Food allergens (NDA), et al.
  Pubblicazione: (2025-05-01)
• Oat beta‐glucans and reduction of postprandial glucose peak: Evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006
  di: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
  Pubblicazione: (2026-02-01)
• Phenolic compounds naturally present in olive oil and lowering of blood LDL‐cholesterol and systolic blood pressure, therefore reducing the risk of coronary heart disease: Evaluation of a health claim pursuant to Article 14 of Regulation (EC) No 1924/2006
  di: EFSA Panel on Nutrition, Novel Foods and Food allergens (NDA), et al.
  Pubblicazione: (2025-05-01)